Consistently, the expression of the senescence marker p16INK4a was increased, whereas the Cyclin D1 expression was reduced by PKR depletion in cisplatin‐ or gemcitabine‐treated NPC cells (Figure 6c). Here, CDKN2A is linked to nasopharyngeal carcinoma.